WASHINGTON -- Business-to-business e-commerce won't succeed without collaboration between manufacturers and retailers, according to a new study. initiatives, according to the study, conducted by ...

Entered into an additional clinical study collaboration and supply agreement with Gilead to evaluate IDE397, IDEAYA’s MAT2A inhibitor, in combination with Trodelvy, Gilead’s Trop-2 directed ADC, in ...

McALLEN, Texas (Border Report) — A new study says U.S. and Mexican collaboration is essential to halting illegal immigration at the border, and it credits Mexico for helping to reduce crossings at the ...

– Entered collaboration with Pfizer to evaluate triplet combination of STX-478 + atirmociclib + fulvestrant in frontline patients with PI3Kα-mutated HR+/HER2- metastatic breast cancer; trial ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new research study sponsored by Tempus and ...

Advarra has integrated its electronic institutional review board (eIRB) system, known as Center for IRB Intelligence (CIRBI), with its single-sign-on-enabled software, Study Collaboration, for ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. McALLEN, Texas (Border Report) — A new study ...

SOUTH SAN FRANCISCO, Calif., Feb. 13, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), a precision medicine oncology company committed to the discovery and development of targeted ...

Pursuant to the clinical study collaboration and supply agreement, IDEAYA and Gilead retain the commercial rights to their respective compounds, including with respect to use as a monotherapy or ...

Entered into Clinical Study Collaboration and Supply Agreement with Gilead to evaluate IDE397, IDEAYA's MAT2A inhibitor, in combination with sacituzumab-govitecan-hziy ("Trodelvy") Gilead's Trop-2 ...